Metabolomic investigations in cerebrospinal fluid of Parkinson's disease.
Ontology highlight
ABSTRACT: The underlying mechanisms of Parkinson´s disease are not completely revealed. Especially, early diagnostic biomarkers are lacking. To characterize early pathophysiological events, research is focusing on metabolomics. In this case-control study we investigated the metabolic profile of 31 Parkinson´s disease-patients in comparison to 95 neurologically healthy controls. The investigation of metabolites in CSF was performed by a 12 Tesla SolariX Fourier transform-ion cyclotron resonance-mass spectrometer (FT-ICR-MS). Multivariate statistical analysis sorted the most important biomarkers in relation to their ability to differentiate Parkinson versus control. The affected metabolites, their connection and their conversion pathways are described by means of network analysis. The metabolic profil
SUBMITTER: Willkommen D
PROVIDER: S-EPMC6287824 | biostudies-literature | 2018
REPOSITORIES: biostudies-literature
ACCESS DATA